[HTML][HTML] Identification of the key genes and characterizations of tumor immune microenvironment in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma …

L Zhang, J Chen, T Cheng, H Yang, H Li… - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
This study aimed to investigate the key genes and immune microenvironment involved in
different TNM stages of lung adenocarcinoma (LUAD) and lung squamous cell carcinoma …

Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer

AH Almalki - Metabolites, 2023 - mdpi.com
Lung cancer is the leading cause of cancer-related death worldwide. Metabolic
reprogramming is a fundamental trait associated with lung cancer development that fuels …

Dysregulation of lipid metabolism induced by airway exposure to polycyclic aromatic hydrocarbons in C57BL/6 mice

F Li, B Xiang, Y Jin, C Li, J Li, S Ren, H Huang… - Environmental …, 2019 - Elsevier
Polycyclic aromatic hydrocarbons (PAHs), originated from cigarette smoke and fine particle
matter (PM2. 5), are important inducers of lung cancer. Lipid metabolic disorder is an …

First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes

J Sieminska, K Miniewska, R Mroz, E Sierko… - Frontiers in Molecular …, 2024 - frontiersin.org
Introduction: Discrimination between adenocarcinoma (ADC) and squamous cell carcinoma
(SCC) subtypes in non-small cell lung cancer (NSCLC) patients is a significant challenge in …

Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse …

X Wang, W Han, J Yang, D Westaway, L Li - Analytica Chimica Acta, 2019 - Elsevier
Tissue metabolomics can play an important role in biological studies and biomarker
discovery. However, high-coverage metabolome analysis of tissue samples remains a …

Exploration of oxidized phosphocholine profile in non-small-cell lung cancer

J Godzien, A Lopez-Lopez, J Sieminska… - Frontiers in Molecular …, 2024 - frontiersin.org
Introduction: Lung cancer is one of the most frequently studied types of cancer and
represents the most common and lethal neoplasm. Our previous research on non-small cell …

Lipid alterations and subtyping maker discovery of lung cancer based on nontargeted tissue lipidomics using liquid chromatography–mass spectrometry

Y Fan, HAA Noreldeen, L You, X Liu, X Pan… - … of Pharmaceutical and …, 2020 - Elsevier
High morbidity and mortality are still associated with lung cancer, especially non-small cell
lung cancer (NSCLC). Although several studies showed abnormality in lung cancer …

Hippocampal Sector–Specific Metabolic Profiles Reflect Endogenous Strategy for Ischemia-Reperfusion Insult Resistance

O Krupska, T Kowalczyk, M Beręsewicz-Haller… - Molecular …, 2021 - Springer
The gerbil is a well-known model for studying cerebral ischemia. The CA1 of the
hippocampus is vulnerable to 5 min of ischemia, while the CA2–4 and dentate gyrus (DG) …

Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo‐YAP signaling pathway

CH Zheng, XM Chen, FB Zhang… - Cell Biology …, 2018 - Wiley Online Library
CXCR4 has been shown to play a key role in the metastasis of non‐small cell lung cancer
(NSCLC). And CXCR may be associated with the Hippo—Yes kinase‐associated protein …

The ability of metabolomics to discriminate non-small-cell lung cancer subtypes depends on the stage of the disease and the type of material studied

T Kowalczyk, J Kisluk, K Pietrowska, J Godzien… - Cancers, 2021 - mdpi.com
Simple Summary The most commonly diagnosed lung cancer is non-small-cell lung cancer
(NSCLC). In contrast, the most frequent subtypes of NSCLC, accounting for 80% of cases …